Association between confocal morphologic classification and clinical phenotypes of multiple primary and familial melanomas

JAMA Dermatology

Volumn 152, Issue 10, 2016, Pages 1099-1105

  Grazziotin, Thais Corsetti ^a,b,c   Alarcon, Ivette ^a   Bonamigo, Renan Rangel ^b   Carrera, Cristina ^a,d   Potrony, Miriam ^a   Aguilera, Paula ^a,d   Puig Butille, Joan Anton ^a,d   Brito, Johanna ^a   Badenas, Celia ^a,d   Alos, Llucia ^a   Malvehy, Josep ^a,d   Puig, Susana ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPILUMINESCENCE MICROSCOPY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HISTOLOGY; HUMAN; HUMAN CELL; IN SITU MELANOMA; LENTIGO MALIGNA MELANOMA; MALE; MELANOMA; NEVOID MELANOMA; PRIORITY JOURNAL; REFLECTANCE CONFOCAL MICROSCOPY; RETROSPECTIVE STUDY; SUPERFICIAL SPREADING MELANOMA; BRAZIL; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GENETICS; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BIOMARKERS, TUMOR; BRAZIL; CROSS-SECTIONAL STUDIES; DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GENES, P16; HUMANS; MALE; MELANOMA; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 84999122225     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2016.1189     Document Type: Article

References (21)

1. Viros A, Fridlyand J, Bauer J, et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med. 2008;5(6):e120.
2. Carrera C, Palou J, Malvehy J, et al. Early stages of melanoma on the limbs of high-risk patients: clinical, dermoscopic, reflectance confocal microscopy and histopathological characterization for improved recognition. Acta Derm Venereol. 2011;91(2):137-146.
3. Alarcon I, Carrera C, Palou J, Alos L, Malvehy J, Puig S. Impact of in vivo reflectance confocal microscopy onthe number needed to treat melanoma in doubtful lesions. Br J Dermatol. 2014; 170(4):802-808.
4. Bassoli S, Maurichi A, Rodolfo M, et al. CDKN2A and MC1R variants influence dermoscopic and confo-cal features of benign melanocytic lesions in multiple melanoma patients. Exp Dermatol. 2013;22(6):411-416.
5. Lovatto L, Carrera C, Salerni G, Alós L, Malvehy J, Puig S. In vivo reflectance confocal microscopy of equivocal melanocytic lesions detected by digital dermoscopy follow-up. J Eur Acad Dermatol Venereol. 2015;29(10):1918-1925.
6. Goldstein AM, Chan M, Harland M, et al; Lund Melanoma Study Group; Melanoma Genetics Consortium (GenoMEL). Features associated with germline CDKN2A mutations: aGenoMEL study of melanoma-prone families from three continents. J Med Genet. 2007;44(2):99-106.
7. Badenas C, Aguilera P, Puig-Butillé JA, Carrera C, Malvehy J, Puig S. Genetic counseling in melanoma. Dermatol Ther. 2012;25(5):397-402.
8. Nelson AA, Tsao H. Melanoma and genetics. Clin Dermatol. 2009;27(1):46-52.
9. Potrony M, Badenas C, Aguilera P, et al. Update in genetic susceptibility in melanoma. Ann Transl Med. 2015;3(15):210.
10. Cuéllar F, Puig S, Kolm I, et al. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers. Br J Dermatol. 2009;160(1):48-53.
11. Pellacani G, De Pace B, Reggiani C, et al. Distinct melanoma types basedon reflectance confocal microscopy. Exp Dermatol. 2014;23(6):414-418.
12. Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.J Am Acad Dermatol. 2003;48(5):679-693.
13. Nachbar F, Stolz W, Merkle T, et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30(4):551-559.
14. Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal microscopy of pigmented skin lesions: improvement inmelanoma diagnostic specificity. J Am Acad Dermatol. 2005;53 (6):979-985.
15. Segura S, Puig S, Carrera C, Palou J, Malvehy J. Development of atwo-step method for the diagnosis of melanoma by reflectance confocal microscopy. J Am Acad Dermatol. 2009;61(2): 216-229.
16. Puig S, Ruiz A, Castel T, et al. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A inamelanoma family witha mutation in the CDKN2A (P16INK4A) gene. Hum Genet. 1997; 101(3):359-364.
17. Puig S, Malvehy J, Badenas C, et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol. 2005;23(13):3043-3051.
18. Badenas C, Torra R, San Millán JL, et al. Mutational analysis within the 3′ region of the PKD1 gene. Kidney Int. 1999;55(4):1225-1233.
19. Puig-Butillé JA, Carrera C, Kumar R, et al. Distribution ofMC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma ina Mediterranean population. Br J Dermatol. 2013;169(4):804-811.
20. Potrony M, Puig-Butillé JA, Aguilera P, et al. Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling. J Am Acad Dermatol. 2014;71(5):888-895.
21. Zalaudek I, Marghoob AA, Scope A, et al. Three roots of melanoma. Arch Dermatol. 2008;144(10):1375-1379.